Skip to Main Content

During a widely anticipated U.K. Parliamentary hearing, Vertex Pharmaceuticals (VRTX) chief executive Jeff Leiden promised to offer “new ideas” for breaking a long-running stalemate over access to a cystic fibrosis medicine when he meets with a government official next week.

“I’m going to come to the meeting with new ideas,” Leiden said about his planned meeting on Monday with Secretary of State Matt Hancock. “And meantime, we would guarantee access to patients at a discount to our list price. I want to get (a pair of government health agencies) back to the table. There’s no reason we can’t find a solution here in England.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!